Distinct pattern of genomic breakpoints in CML and BCR:: ABL1-positive ALL: analysis of 971 patients L Hovorkova, L Winkowska, J Skorepova, M Krumbholz, A Benesova, ... Molecular Cancer 23 (1), 1-7, 2024 | | 2024 |
Erratum to: Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard risk acute myeloid leukemia M Maurer-Granofszky, S Köhrer, S Fischer, A Schumich, K Nebral, ... Haematologica 109 (7), 2379, 2024 | | 2024 |
CRISPR/Cas9-mediated KMT2A-rearrangements for the development of leukaemia mouse models T Benz, P Larghero, C Meyer, D Brüggmann, AE Hentrich, R Bhayadia, ... Klinische Pädiatrie 236 (03), 0006, 2024 | | 2024 |
The KMT2A/MLL consensus gene structure: a comprehensive update for research and diagnostic implications C Meyer, P Larghero, BA Lopes, R Marschalek Leukemia, 1-4, 2024 | | 2024 |
Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia T Burmeister, AS Ströh, B Kehden, H Trautmann, C Meyer, R Marschalek, ... Leukemia, 1-4, 2024 | | 2024 |
Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia M Maurer-Granofszky, S Köhrer, S Fischer, A Schumich, K Nebral, ... Haematologica 109 (3), 740, 2024 | 3 | 2024 |
Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study M Zaliova, J Zuna, L Winkowska, I Janotova, J Skorepova, J Lukes, ... Leukemia 38 (1), 21-30, 2024 | 1 | 2024 |
Independent Prognostic Value of DNA-Based Minimal Residual Disease Assessment in Unselected Population-Based Cohort of Pediatric Acute Myeloid Leukemia M Zaliova, J Zuna, L Winkowska, I Janotova, J Skorepova, J Lukes, ... Blood 142, 4327, 2023 | | 2023 |
Distinct Pattern of ABL1 Genomic Breakpoints in Chronic Myeloid Leukemia and BCR:: ABL1-Positive Acute Lymphoblastic Leukemia: Analysis of 884 Patients with Minor and Major BCR … L Hovorkova, L Winkowska, J Krotka, M Krumbholz, C Meyer, R Sutton, ... Blood 142, 1605, 2023 | | 2023 |
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study R Kim, H Bergugnat, C Pastoret, F Pasquier, E Raffoux, L Larcher, ... Blood 142 (21), 1806-1817, 2023 | 5 | 2023 |
A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features C Bueno, R Torres-Ruiz, T Velasco-Hernandez, O Molina, P Petazzi, ... Blood 142 (20), 1752-1756, 2023 | | 2023 |
P337: IKZF1 DELETIONS IN B-ALL: FROM ITS GENETIC BASIS TO DIAGNOSTIC ENHANCEMENT BA Lopes, C Meyer, H Bouzada, M Külp, ALT Maciel, P Larghero, ... HemaSphere 7 (S3), e5507229, 2023 | | 2023 |
P315: TP53 ALTERATIONS AND MRD REFINE PROGNOSIS OF ADULT KMT2A-REARRANGED B-ALL R Kim, H Bergugnat, F Pasquier, E Raffoux, L Larcher, M Passet, ... HemaSphere 7 (S3), e7342363, 2023 | | 2023 |
The recombinome of IKZF1 deletions in B-cell precursor ALL BA Lopes, C Meyer, H Bouzada, M Külp, ALT Maciel, P Larghero, ... Leukemia 37 (8), 1727-1731, 2023 | | 2023 |
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome M Külp, P Larghero, J Alten, G Cario, C Eckert, A Caye-Eude, H Cavé, ... Leukemia 37 (6), 1216-1233, 2023 | 1 | 2023 |
The KMT2A recombinome of acute leukemias in 2023 C Meyer, P Larghero, B Almeida Lopes, T Burmeister, D Gröger, R Sutton, ... Leukemia 37 (5), 988-1005, 2023 | 56 | 2023 |
The recombinome of IKZF1 deletions in B-ALL B Lopes, C Meyer, H Bouzada, M Külp, AL Maciel, P Larghero, T Barbosa, ... | | 2023 |
Molecular Characterization of 34 Children with Acute Leukemia and MLL gene Rearrangements in Argentina AP Mansini, C Meyer, M Gallego, PL Rubio, A Medina, M Coccé, J Rossi, ... Fortune Journal of Health Sciences 6, 508-516, 2023 | | 2023 |
3109–IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A:: AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA M Külp, P Larghero, J Alten, G Cario, C Eckert, A Caye-Eude, H Cavé, ... Experimental Hematology 124, S104, 2023 | | 2023 |
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia R Tirtakusuma, K Szoltysek, P Milne, VV Grinev, A Ptasinska, PS Chin, ... Blood, The Journal of the American Society of Hematology 140 (17), 1875-1890, 2022 | 37 | 2022 |